Cholesterol Ratio Calculator

Table of Contents

What exactly is PSA?

Cholesterol is a fat substance found in your body and the ratio shows if good HDL balances your total cholesterol.

Low ratio (<3.5) indicates low risk of heart disease, whilst a high ratio (>5.0) is strongly linked to blocked arteries.

Improvement in the cholesterol ratio is possible. Most can expect to see better ratio in 8-12 weeks.

Total cholesterol on its own doesn't give the complete picture:

  • Looking at total cholesterol number alone can be misleading. Lets follow the example below to understand this.
  • Two people, both with 200 total cholesterol:
    • Person A has 80 HDL cholesterol, Person A's ratio: 200/80 = 2.5 (great news!) 
    • Person B has 40 HDL. Person B's ratio: 200/40 = 5.0 (not so great)
    • By comapring the ratio of "good" HDL to total cholesterol, it shows hidden risks which would not be obvious from looking at the total cholesterol alone.
 

Low and High ratio thresholds:

  • Low ratio (under 3.5) = A ratio below 3.5 means your HDL works to effectively clears out artery preventing clogging. This cuts heart attack/stroke risk by 50-70% compared to high ratios. 
  • High ratio (above 5.0) = Ratios over 5.0 indicate not enough HDL needed to clean up "bad" LDL, tripling heart disease risk. Next steps: Get a full lipid panel (LDL, triglycerides) and a blood pressure check. You can improve your ratio: Diet: Swap white bread for oats, add heart-healthy fats like walnuts/avocados to boost HDL by 15% Exercise: 150 mins/week brisk walking drops ratio by 20% in 3 months

 

Ratio can be improved with the right changes:

  • To improve your cholesterol ratio, make changes in your diet and lifestyle. The key is to be consistent with the changes. So planning achievable changes based on your day to day life is important.
  • Dietary changes revolve around healthy fats with plenty of fruit and vegetables giving you plenty of vitamins and fibre. Practical steps could be to swap white bread for oats, add heart-healthy fats like walnuts/avocados to boost HDL.
  • As for exercise you can start off with brisk walking aiming for 150 mins a week. Quit smoking if you smoke, and keep a healthy weight.

How to use Cholesterol Ratio Calculator

 

How to use the calculator in 4 steps:

 

  1. Find your Total Cholesterol and HDL Cholesterol values from your blood test report.
  2. Select the correct unit (mg/dL or mmol/L).
  3. Enter your values into the fields below and click "Calculate" to get your cholesterol ratio.
  4. If you need to redo, click "Reset" to start fresh.

 

**All information is private, no data is saved or shared. You can print your results for easy reference or to share with your doctor or healthcare provider.**

 

Cholesterol Ratio Calculator

Web → PDF (URL + Timestamp)
Paste a URL, preview, then print to PDF with a footer.
Paste a URL above and click Load Preview.
If a site blocks embedding, you’ll see an error.
Note: This tool prints what you see in the preview area. Some websites disallow embedding in iframes (security headers like X-Frame-Options / frame-ancestors). Those won’t load here.

FAQs

Q1. What’s the difference between Cholesterol Ratio and Triglyceride/HDL Ratio?


  • PSAD above 0.20 ng/mL/cc -  Higher prostate cancer risk
  • PSAD between 0.10-0.15 ng/mL/cc - Intermediate cancer risk
  • PSAD below 0.10 ng/mL/cc - Lower risk for significant disease.

Q2. What will happen if my PSA is raised?


  • First, confirm raised PSA by repeating the test, importantly after addressing any temporary causes such as infections that could have caused it. 
    • Additional tests like free-to-total PSA ratio or MRI can help assess prostate health. 
  • Then a shared decision making process guides what further steps to be taken based on test results and individual patient factors.

Q3. Does a high PSA mean I have cancer?


  • No, high PSA doesn't always mean cancer. Many non-cancerous conditions can cause high PSA. 
    • About 70% of elevated PSA results are false positives, with only 25% of biopsies finding cancer. 
  • Doctors consider multiple factors, including age and other tests, to get a better assessment of prostate health.

Q4. What is Normal PSA Density by Age?


  • Below 50 years: Normal PSAD is usually below 0.10 ng/mL²
  • 50-59 years: PSAD up to 0.15 ng/mL² can be considered normal. 
  • 60-69 years: Normal PSAD can reach 0.20 ng/mL².
  • over 70 years: PSAD may approach 0.25 ng/mL².

Q5. What medications can increase PSA levels?


  • Testosterone replacement therapy, especially intramuscular injections, can raise PSA. 
  • Corticosteroids, like betamethasone, can also increase PSA levels in some cases. 
  • On the other hand, medications such as 5α-reductase inhibitors (eg. Finasteride, Dutasteride), NSAIDs, statins, and thiazide diuretics can lower PSA levels.

Q6. What can cause a false high PSA reading?


  • Recent ejaculation can lead PSA rising temporarily, especially in men over 50. 
  • Intense exercise such as cycling, or physical activities involving the prostate can also increase PSA levels. 
  • Prostate infections, swelling, or certain medical procedures like having a catheter can result in higher PSA readings.

Q7. How to Lower PSA Levels?


  • Evidence suggests incorporate dietary changes like consuming cooked tomato products rich in lycopene, a powerful antioxidant, can help.
  • Adopting a healthy lifestyle with regular exercise, stress management, and increased fibre intake.

  • Consult healthcare providers before making any significant changes to your diet or start supplementing. They can help you with creating a personalised plan that works for you whether it be natural approach or using tried and tested medicines.

References

1. Chang, S.L., Harshman, L.C. and Presti, J.C. (2010). Impact of Common Medications on Serum Total Prostate-Specific Antigen Levels: Analysis of the National Health and Nutrition Examination Survey. Journal of Clinical Oncology, 28(25), pp.3951–3957. doi:https://doi.org/10.1200/jco.2009.27.9406. Link 


2. Cornford, P., van den Bergh, R.C.N., Briers, E., Van den Broeck, T., Brunckhorst, O., Darraugh, J., Eberli, D., De Meerleer, G., De Santis, M., Farolfi, A., Gandaglia, G., Gillessen, S., Grivas, N., Henry, A.M., Lardas, M., van Leenders, G.J.L.H., Liew, M., Linares Espinos, E., Oldenburg, J. and van Oort, I.M. (2024). EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent. European Urology, [online] 86(2), pp.S0302-2838(24)022541. doi:https://doi.org/10.1016/j.eururo.2024.03.027. Link


3. Cunningham, G.R., Ellenberg, S.S., Bhasin, S., Matsumoto, A.M., Parsons, J.K., Preston, P., Cauley, J.A., Gill, T.M., Swerdloff, R.S., Wang, C., Ensrud, K.E., Lewis, C.E., Pahor, M., Crandall, J.P., Molitch, M.E., Cifelli, D., Basaria, S., Diem, S.J., Stephens-Shields, A.J. and Hou, X. (2019). Prostate-Specific Antigen Levels During Testosterone Treatment of Hypogonadal Older Men: Data from a Controlled Trial. The Journal of Clinical Endocrinology & Metabolism, [online] 104(12), pp.6238–6246. doi:https://doi.org/10.1210/jc.2019-00806. Link


4. Grammatikopoulou, M.G., Gkiouras, K., Papageorgiou, S.Τ., Myrogiannis, I., Mykoniatis, I., Papamitsou, T., Bogdanos, D.P. and Goulis, D.G. (2020). Dietary Factors and Supplements Influencing Prostate-Specific Antigen (PSA) Concentrations in Men with Prostate Cancer and Increased Cancer Risk: An Evidence Analysis Review Based on Randomized Controlled Trials. Nutrients, [online] 12(10). doi:https://doi.org/10.3390/nu12102985. Link


5. Hébert, J.R., Hurley, T.G., Harmon, B.E., Heiney, S., Hebert, C.J. and Steck, S.E. (2012). A diet, physical activity, and stress reduction intervention in men with rising prostate-specific antigen after treatment for prostate cancer. Cancer Epidemiology, 36(2), pp.e128–e136. doi:https://doi.org/10.1016/j.canep.2011.09.008. Link


6. Lumbreras, B., Parker, L.A., Caballero-Romeu, J.P., Gómez-Pérez, L., Puig-García, M., López-Garrigós, M., García, N. and Hernández-Aguado, I. (2022). Variables Associated with False-Positive PSA Results: A Cohort Study with Real-World Data. Cancers, [online] 15(1), p.261. doi:https://doi.org/10.3390/cancers15010261. Link


7. Madej, A., Wilkosz, J., Różański, W. and Lipiński, M. (2012). Complication rates after prostate biopsy according to the number of sampled cores. Central European Journal of Urology, [online] 65(3), pp.116–118. doi:https://doi.org/10.5173/ceju.2012.03.art3. Link


8. Pellegrino, F., Tin, A.L., Martini, A., Vertosick, E.A., Porwal, S.P., Stabile, A., Giorgio Gandaglia, Eastham, J.A., Briganti, A., Montorsi, F. and Vickers, A.J. (2022). Prostate-specific Antigen Density Cutoff of 0.15 ng/ml/cc to Propose Prostate Biopsies to Patients with Negative Magnetic Resonance Imaging: Efficient Threshold or Legacy of the Past? European Urology Focus, 9(2), pp.291–297. doi:https://doi.org/10.1016/j.euf.2022.10.002. Link


9. Rajaei, M., Momeni, A., Soleiman Kheiri and Hafez Ghaheri (2013). Effect of ejaculation on serum prostate specific antigen level in screening and non-screening population. Journal of Research in Medical Sciences : The Official Journal of Isfahan University of Medical Sciences, [online] 18(5), p.387. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC3810571/ [Accessed 17 Jun. 2025]. Link


10. Rajendran, I., Lee, K.-L., Liness Thavaraja and Barrett, T. (2023). Risk stratification of prostate cancer with MRI and prostate-specific antigen density-based tool for personalized decision making. ˜The œBritish journal of radiology/British journal of radiology, 97(1153), pp.113–119. doi:https://doi.org/10.1093/bjr/tqad027. Link


11. Uroweb - European Association of Urology. (n.d.). EAU Guidelines on Prostate Cancer - Uroweb. [online] Available at: https://uroweb.org/guidelines/prostate-cancer [Accessed 17 Jun. 2025]. Link


12. van Renterghem, K., Van Koeveringe, G., Achten, R. and van Kerrebroeck, P. (2009). A new algorithm in patients with elevated and/or rising prostate-specific antigen level, minor lower urinary tract symptoms, and negative multisite prostate biopsies. International Urology and Nephrology, 42(1), pp.29–38. doi:https://doi.org/10.1007/s11255-009-9596-z. Link


13. Wei, J.T., Barocas, D., Carlsson, S., Coakley, F., Eggener, S., Etzioni, R., Fine, S.W., Han, M., Kim, S.K., Kirkby, E., Konety, B.R., Miner, M., Moses, K., Nissenberg, M.G., Pinto, P.A., Salami, S.S., Souter, L., Thompson, I.M. and Lin, D.W. (2023). Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening. Journal of Urology, 210(1). doi:https://doi.org/10.1097/ju.0000000000003491. Link